ABSTRACT
Abstract .................................................................................................................342 11.1 Introduction ...............................................................................................342 11.2 Introduction to QSAR ................................................................................345 11.3 QSAR Studies of 1,4 Benzodiazepines as CCKA Antagonist ...................348 11.4 Conclusions ................................................................................................353 Keywords ..............................................................................................................354 References .............................................................................................................354
